Atlantic Gastroenterology Associates, based in Egg Harbor Township, N.J., is one of 20 clinics currently studying a new treatment for Hepatitis C, according to a report by The Body.
The new treatment is designed to be less invasive than the current interferon therapy. Instead of a 24 to 48 week course of injections, the new treatment is being administered as oral polymerase and protease inhibitors taken over a 12 week period.
The new treatment has thus far shown a 95 percent cure rate, 15 percent better than the interferon therapy cure rate.
More Articles on Gastroenterology:
LA Peer Health System Hosts Review of Barrett's Esophagus Articles
Huntington Hospital Appoints Dr. David Rivadeneira Surgical Services Director
Dr. Harold Kaplan Teaches at Quinnipac University Medical School
The new treatment is designed to be less invasive than the current interferon therapy. Instead of a 24 to 48 week course of injections, the new treatment is being administered as oral polymerase and protease inhibitors taken over a 12 week period.
The new treatment has thus far shown a 95 percent cure rate, 15 percent better than the interferon therapy cure rate.
More Articles on Gastroenterology:
LA Peer Health System Hosts Review of Barrett's Esophagus Articles
Huntington Hospital Appoints Dr. David Rivadeneira Surgical Services Director
Dr. Harold Kaplan Teaches at Quinnipac University Medical School